GenoMed4All’s key results on Sickle Cell Disease have been presented during the 4th Global Congress on SCD, which took place in Paris on June 16th.
- Our colleague Maria Paola Boaro (Università di Padova) lead an oral presentation on GenoMed4All’s results on radiomics and AI to identify silent infarcts.
- Amira Idrizovic (VHIR) presented a poster of our work in the integration of diagnosis of SCD patients for precision medicine.
Take a look at all the progress so far and discover what’s yet to come!
The use of Artificial Intelligence (AI) for personalized medicine has recently guided improvements in the diagnostic pathway of many diseases. The EU Project GENOMED4ALL: “Genomics and personalized Medicine for All through Artificial Intelligence in Haematological Diseases” aims at using European data of patients affected by Sickle Cell Disease (SCD) to find correlation between -omics data – and phenotype, seizing the opportunity to improve diagnostics through AI.
